YH14617

· Yuhan Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YH14617, covering 2015-02-18 to 2015-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of YH14617 in Diabetes Mellitus [Phase 2]